Synopses & Reviews
The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Particularly in the already highly globalized pharmaceutical industry, innovation processes have changed considerably in the last 15 - 20 years. One-dimensional, linear single-actor type processes are being replaced by multi-dimensional, complex, multi-actor schemes. As a consequence, new players are becoming more important, with biotechnology firms playing a key role. This study analyzes these new ways in drug development in pharmaceuticals within the concept of "national systems of innovations" as well as from the perspectives of different actors, and collects a lot of empirical evidence for the assumed type of changes, its repercussion on significant input measures and on the differing performance of national pharmaceutical industries.
Table of Contents
A. Jungmittag, G. Reger, T. Reiss: Introduction.- New Ways in Drug Development: Changes of the Locus of Innovation.- Research Approach.-
A. Jungmittag: The National System of Innovation in the United States in Germany.- The Concept of the "Systems of Innovation" Approach.- Systems of Innovation in the German and US Pharmaceutical Sector.-
A. Jungmittag, G. Reger: Dynamics of the Markets and Market Structure.- Introduction: Market Categories and Structure.- Production, Consumption and Employment.- Foreign Trade and Foreign Direct Investment.- Conclusions for the International Competitiveness of Selected Countries.-
T. Reiss, S. Hinze: Innovation Process and Techno-scientific Dynamics.- Innovation Process in Pharmaceuticals.- Techno-Scientific Changes.-
A. Hullmann: Generation, Transfer and Exploitation of New Knowledge.- Changes in the Division of Labor.- Alliances of Pharmaceutical Firms.- Results of the Empirical Analyses.- Conclusions.-
G. Reger: Internationalization of Research and Development in Pharmaceuticals.- Introduction.- R&D and Technological Specialization on Country Level.- Internationalization Strategies of Selected Pharmaceutical Companies.- Conclusions.-
S. Hinze, T. Reiss: Case Study on New Therapies for Selected Autoimmune Diseases.- Introduction.- Statistical Analysis.- Core Success Factors for Companies in this Field.- Internationalization and Cooperation.- New Distribution of Roles in the R&D Process.- Conclusions.-
A. Jungmittag, G. Reger, T. Reiss: Summary and Conclusions.- Changes in the Innovation Process and Conclusions for R&D-performing Actors.- Conclusions for Research and Technology Policy.